Vista Equipo: Chronic intrathecal baclofen administration in severe spasticity

Chronic intrathecal baclofen administration in severe spasticity

On the basis of previous experimental and clinical studies, 14 patients with severe spasticity due to central or spinal cord damage, resistant to all conservative treatments, were selected after a percutaneous trial period for chronic intrathecal baclofen infusion by programmable pumps. The agent wa...

Descripción completa

Detalles Bibliográficos
Autores Principales:	Broseta, J., Garcia-March, G., Sánchez-Ledesma, M.J., Anaya, Juan-Manuel, Silva, I.
Formato:	Artículo (Article)
Lenguaje:	Inglés (English)
Publicado:	Karger AG 1990
Materias:	Baclofen Spasticity Programmable pumps Spinal infusion
Acceso en línea:	https://repository.urosario.edu.co/handle/10336/27366 https://doi.org/10.1159/000100205

id	ir-10336-27366
recordtype	dspace
spelling	ir-10336-273662021-08-05T22:27:53Z Chronic intrathecal baclofen administration in severe spasticity Administración crónica de baclofeno intratecal en espasticidad severa Broseta, J. Garcia-March, G. Sánchez-Ledesma, M.J. Anaya, Juan-Manuel Silva, I. Baclofen Spasticity Programmable pumps Spinal infusion On the basis of previous experimental and clinical studies, 14 patients with severe spasticity due to central or spinal cord damage, resistant to all conservative treatments, were selected after a percutaneous trial period for chronic intrathecal baclofen infusion by programmable pumps. The agent was delivered at C4 in quadriplegic patients or in cases with central spasticity and in the neighbouring areas on the affected segments in paraplegic patients. The daily baclofen dose varied from 25 to 260 µg and was infused in a bolus, continuously infused or both combined according to the results during the trial period. After a mean follow-up period of 11 months, constant decrease of rigidity, absence of spasms, improvement of bladder function, cramping pain remission, and moderate improvement in walking capacity and transfer activities were usually observed. Neither complications nor side effects were noted. 1990-11-28 2020-08-19T14:41:54Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion ISSN: 1011-6125 EISSN: 1423-0372 https://repository.urosario.edu.co/handle/10336/27366 https://doi.org/10.1159/000100205 eng info:eu-repo/semantics/restrictedAccess application/pdf Karger AG Stereotactic and Functional Neurosurgery
institution	EdocUR - Universidad del Rosario
collection	DSpace
language	Inglés (English)
topic	Baclofen Spasticity Programmable pumps Spinal infusion
spellingShingle	Baclofen Spasticity Programmable pumps Spinal infusion Broseta, J. Garcia-March, G. Sánchez-Ledesma, M.J. Anaya, Juan-Manuel Silva, I. Chronic intrathecal baclofen administration in severe spasticity
description	On the basis of previous experimental and clinical studies, 14 patients with severe spasticity due to central or spinal cord damage, resistant to all conservative treatments, were selected after a percutaneous trial period for chronic intrathecal baclofen infusion by programmable pumps. The agent was delivered at C4 in quadriplegic patients or in cases with central spasticity and in the neighbouring areas on the affected segments in paraplegic patients. The daily baclofen dose varied from 25 to 260 µg and was infused in a bolus, continuously infused or both combined according to the results during the trial period. After a mean follow-up period of 11 months, constant decrease of rigidity, absence of spasms, improvement of bladder function, cramping pain remission, and moderate improvement in walking capacity and transfer activities were usually observed. Neither complications nor side effects were noted.
format	Artículo (Article)
author	Broseta, J. Garcia-March, G. Sánchez-Ledesma, M.J. Anaya, Juan-Manuel Silva, I.
author_facet	Broseta, J. Garcia-March, G. Sánchez-Ledesma, M.J. Anaya, Juan-Manuel Silva, I.
author_sort	Broseta, J.
title	Chronic intrathecal baclofen administration in severe spasticity
title_short	Chronic intrathecal baclofen administration in severe spasticity
title_full	Chronic intrathecal baclofen administration in severe spasticity
title_fullStr	Chronic intrathecal baclofen administration in severe spasticity
title_full_unstemmed	Chronic intrathecal baclofen administration in severe spasticity
title_sort	chronic intrathecal baclofen administration in severe spasticity
publisher	Karger AG
publishDate	1990
url	https://repository.urosario.edu.co/handle/10336/27366 https://doi.org/10.1159/000100205
_version_	1712098552187977728
score	12,131701

Chronic intrathecal baclofen administration in severe spasticity

Ejemplares similares